HHLR Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History
Bought
Maintained
Sold
Other funds holding NBP
SL
ACM
CS
WP
EAM
HHLR Advisors's NBP Position: Q1 2026 in Review
HHLR Advisors held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q1 2026 at 5,980,568 shares worth $14.7M. The position accounts for 0.88% of the portfolio, ranked #12.
HHLR Advisors first reported a position in NBP in Q3 2020 and has held it in 23 quarters since. The position peaked at $555M in Q2 2021. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.
- HHLR Advisors held 5,980,568 shares of NovaBridge Biosciences American Depositary Shares worth $14.7M as of Q1 2026.
- HHLR Advisors left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q1 2026.
- NovaBridge Biosciences American Depositary Shares made up 0.88% of HHLR Advisors's portfolio in Q1 2026, its #12 holding.
- HHLR Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and has held it in 23 quarters since.
- HHLR Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $555M in Q2 2021.
- 48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.
Based on HHLR Advisors's 13F filing for Q1 2026, filed 15 May 2026.